For Investors
Strategic growth from elite athletics to corporate wellness and pharmaceutical spinoffs.
Log in to Investor PortalCurrent Status
NLN is currently in its pre-seed phase, focusing on developing IPR, securing the supply chain, and establishing proof of efficacy and safety through rigorous testing.
Market Roadmap
1
Phase 1: Pro-Sports
2
Phase 2: High-performance corporate wellness
3
Phase 3: General corporate, insurer & Medicare wellness
4
Phase 4: General consumer wellness and Otx
5
Phase 5: FDA Botanical Drug development spinoff
IP Strategy
Proprietary technology centered on biorhythmic dosing systems and bioavailability optimization. Additional trade secrets developed internally, such as in the PhytoMind research engine architecture and a growing research network.
🔒
Request Data Room Access
To view financial projections and detailed business plans, please request an access code.